focus -WSS

focus

author：fashion 2025-09-06 03:40:01 - browse：18

3D dollar signs come out of a prescription drug bottle — coverage from STAT — Adobe

WASHINGTON — Venture capitalists are still pouring money into drug research in spite of Medicare’s new power to negotiate drug prices, according to Congress’ nonpartisan budget experts.

The Inflation Reduction Act includes two measures that directly lower drug prices. Medicare price negotiation is the most controversial of the two. The law gives drugs 9 years on the market before negotiated prices take effect; biologics get 13 years. Drugs are selected for negotiation among the 50 top-selling drugs without generic or biosimilar competition. Medicare will negotiate prices for 10 drugs to start. Up to 60 drugs will be subject to negotiation over the next four years, and up to 20 more drugs every year afterward.

The law also requires drug companies to pay back Medicare when they raise prices on drugs faster than inflation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： First medicine developed to treat MASH expected to be approved soon

focus

WSS

States increasingly look to regulate hospital facility fees

NEJM study link tiny plastics in blood vessels to heart problems

UnitedHealth quietly bought dozens of outpatient centers

Celebrate National Dole Whip Day for 3 days this week at Disney

Seattle police shoot person suspected in downtown stabbing

The kidney, in all its complexity, is captured in a new atlas

focus

focus

focus

In Memoriam: Notable people who died in 2023

DOJ, FTC to increase scrutiny of all types of health care mergers

New air purifier tech could be key to improving indoor air quality

The Readout: Amylyx, Alumis, and Lundbeck drug updates

State Dept. review finds Biden bears some blame for Afghanistan failures

'Reaching a detente': STAT's Helen Branswell on covering Covid

Hepatitis C has a cure — but many Americans still lack access to it

Precocious puberty in girls comes with mental health risks

Virginia high school admissions case could be legal follow

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

focus

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Precocious puberty in girls comes with mental health risks

Amylyx ALS drug failure raises questions and concerns

Stanford updates investigation of president’s past research

Novo Nordisk obesity pill bests Wegovy in early trial

IVF, abortion rights issues kick off Biden’s State of the Union

focus

focus

focus

leisure time